ExLibris header image
SFX Logo
Title: Gene editing fixes cystic fibrosis gene in mice before birth
Source:

Nature Medicine [1078-8956] Mullin, Emily yr:2019


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "Highly Efficient Gene Editing of Cystic Fibrosis Patient-Derived Airway Basal Cells Results in Functional CFTR Correction." Molecular therapy. 28.7: 1684-1695. Link to SFX for this item
2. "250 Establishing predictive models for therapeutic development of cystic fibrosis gene editing." Journal of cystic fibrosis. 22. Link to SFX for this item
3. "Epigenome editing of the CFTR-locus for treatment of cystic fibrosis." Journal of cystic fibrosis. 21.1: 164-171. Link to SFX for this item
4. "317 AW1282X mouse model for cystic fibrosis and in vitro correction of the phenotype by pharmacologics and gene editing." Journal of cystic fibrosis. 22. Link to SFX for this item
5. "On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis." Frontiers in pharmacology. 12: 662110-662110. Link to SFX for this item
6. "High-Efficiency, Selection-free Gene Repair in Airway Stem Cells from Cystic Fibrosis Patients Rescues CFTR Function in Differentiated Epithelia." Cell stem cell. 26.2: 161-. Link to SFX for this item
7. Frangoul H, H. "CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia." The New England journal of medicine. 384.3: 252-260. Link to SFX for this item
8. "CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia." New England journal of medicine 384.23. Link to SFX for this item
9. "CRISPR/Cas9 gene editing for curing sickle cell disease." Transfusion and apheresis science 60.1: 103060-103060. Link to SFX for this item
10. Esrick, Erica B. "Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease." The New England Journal of Medicine 384.3 (2021): 205-215. Link to SFX for this item
11. "Application of CRISPR/Cas9 in Alzheimer’s Disease." Frontiers in neuroscience. 15: 803894-803894. Link to SFX for this item
12. Graham, S. "CRISPR/Cas9 gene editing therapies for cystic fibrosis." Expert opinion on biological therapy 21.6 (2021): 1-14. Link to SFX for this item
13. Chow, Michael Y.T., H. "Inhalation delivery technology for genome-editing of respiratory diseases." Advanced drug delivery reviews 168 (2021): 217-228. Link to SFX for this item
14. McCarron A, A. "Phenotypic characterization and comparison of Phe508del and cystic fibrosis transmembrane conductance regulator (CFTR) knockout rat models of cystic fibrosis generated by CRISPR/Cas9 gene editing." The American journal of pathology. 190.5: 977-993. Link to SFX for this item
15. Haapaniemi, E. "CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response." Nature Medicine 24.7 (2018): 927-930. Link to SFX for this item
16. "A defective flexible loop contributes to the processing and gating defects of the predominant cystic fibrosis-causing mutation." The FASEB journal. 33.4: 5126-5142. Link to SFX for this item
17. White, M. "A frame-shift mutation in the cystic fibrosis gene." Nature 344.6267 (1990): 665-7. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.